Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-25

Clinical Trial Update: FTIH Study of ECC0509 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial of ECC0509 in healthy volunteers has completed; the study investigated safety and pharmacology, with nonalcoholic steatohepatitis and osteoarthrit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ECC0509

Snippet

Sponsor: Eccogene | Conditions: Nonalcoholic Steatohepatitis, Osteoarthritis | Phase 1 | Status: COMPLETED